Cover Image
市場調查報告書

Sezary症候群:全球臨床實驗趨勢

Sezary Syndrome Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 231140
出版日期 內容資訊 英文 153 Pages
訂單完成後即時交付
價格
Back to Top
Sezary症候群:全球臨床實驗趨勢 Sezary Syndrome Global Clinical Trials Review, H1, 2016
出版日期: 2016年01月31日 內容資訊: 英文 153 Pages
簡介

本報告提供全球Sezary症候群治療藥的臨床試驗情形調查,提供您各階段,各進展狀況,主要國家的Sezary症候群相關臨床實驗數量,主要企業·機關的簡介等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:Sezary症候群臨床實驗數量佔腫瘤臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:Sezary症候群臨床實驗數量佔腫瘤臨床實驗數量比率

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - Sezary症候群治療藥

有潛力的藥劑

臨床實驗簡介的基本資料

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3210CTIDB

GlobalData's clinical trial report, "Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Sezary Syndrome to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Sezary Syndrome to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Sezary Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Region, 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Sezary Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Sezary Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Proportion of Sezary Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Sezary Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Sezary Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Sezary Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top